Bristol-Myers Squibb Cuts FY26 EPS Outlook, Raises Revenue Forecast
Bristol-Myers Squibb lowered its fiscal 2026 earnings outlook while raising its annual revenue forecast.
Story updates
12:08:54 PM UTC
SquawkNews
更正-更新版 1-百时美施贵宝上调2026年营收预期，因计提费用下调每股收益预期 将第2段中的“一次性”金额从60美分更正为58美分 将2026年营收预测上调至497.5亿美元至502.5亿美元 20
12:08:58 PM UTC
SquawkNews
訂正-UPDATE 1-ブリストル、2026年売上見通し上げ、特損でEPS下方修正 第2段落の「1回限り」の記述を、60セントから58セントに訂正 ２０２６年の売上高予想を４９７億５,０００万ドル～５
12:09:04 PM UTC
SquawkNews
정정-종합 1-브리스톨 마이어스, 2026년 매출 전망치 상향 조정했으나 비용 반영으로 주당순이익(EPS) 전망치 하향 조정 2번째 문단의 일회성 비용을 60센트에서 58센트로 정
NEW YORK CITY (dpa-AFX) - While reporting financial results for the third quarter on Thursday, Bristol-Myers Squibb Co. (BMY) slashed its earnings guidance for the full-year 2026, while raising annual revenue outlook.For fiscal 2026, the company now projects earnings in a range of about $6.35 to $6…